Drug
Azelaic acid clinical trials
Also written Finacea.
- studies test it
- 25
- open now
- 1
- in phase 3
- 4
- first study started
- 2002
Keep track of what changes. Save the azelaic acid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
25 studies that test it; most in 2010 (5)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 3
- Phase 2
- 4
- Phase 3
- 4
- Phase 4
- 11
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
- Rosacea
- 12
Who runs them
Industry 13 · Other 12
LEO Pharma (6) · Galderma R&D (3) · Wake Forest University Health Sciences (2) · Taro Pharmaceuticals USA (2) · Derm Research, PLLC (2) · University of Guadalajara (1) · Gujranwala medical college District Headquarters Hospital, Gujranwala (1) · Dermatology Specialists Research (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses azelaic acid is read from its arms, and is right about nine times in ten.
Testing it · 25
- Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing RadiationRecruitingPhase 1Virginia Commonwealth UniversityNCT06966388Written as Azelaic Acid
- Efficacy and Safety of a Combined Topical Formula Versus Placebo in Patients With MelasmaCompletedNot applicableUniversity of GuadalajaraNCT07727954Written as Topical azelaic acid 12% plus tranexamic acid 5%
- Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)Active, not recruitingEarly Phase 1Wake Forest University Health SciencesNCT05416333Written as azelaic acid
- Azelaic Acid 20% vs Hydroquinone 4% in Epidermal MelasmaCompletedNot applicableGujranwala medical college District Headquarters Hospital, GujranwalaNCT07327983Written as Topical Azelaic Acid 20% Cream
- To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical GelCompletedPhase 1Taro Pharmaceuticals USANCT03094403Written as Azelaic Acid 15% topical gel
- A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the FaceCompletedPhase 2LEO PharmaNCT00408330Written as Azelaic Acid 15% Gel
- Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate AcneCompletedPhase 3LEO PharmaNCT00031096Written as Azelaic Acid Gel 15% (Finacea, BAY39-6251)
- A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral DermatitisCompletedPhase 2LEO PharmaNCT00403949Written as Azelaic acid 15% gel
- A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once DailyCompletedPhase 4LEO PharmaNCT00417937Written as azelaic acid 15% gel
- Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of RosaceaCompletedPhase 3Galderma R&DNCT01659853Written as azelaic acid gel 15%
- Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy SkinCompletedPhase 4Galderma R&DNCT01139008Written as azelaic acid 15% gel
- Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy SkinCompletedPhase 4Galderma R&DNCT01139047Written as azelaic acid 15% gel
- Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne RosaceaCompletedPhase 4Dermatology Specialists ResearchNCT05014906Written as Azelaic acid
- A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial RosaceaCompletedPhase 3Actavis Inc.NCT02120924Written as Azelaic acid
- Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in RosaceaCompletedPhase 2LEO PharmaNCT00617903Written as Azelaic acid
- Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular RosaceaCompletedPhase 4LEO PharmaNCT00855595Written as Azelaic acid (Finacea, BAY39-6251)
- Azelaic Acid Foam 15% in the Treatment of Papulopustular RosaceaCompletedPhase 4Clinical Research Center of the CarolinasNCT03418610Written as Azelaic Acid foam 15%
- To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial RosaceaCompletedPhase 1Taro Pharmaceuticals USANCT03689010Written as Finacea® (Azelaic acid Foam) 15%
- Combination Gel and Vascular ND in Mild to Moderate RosaceaCompletedNot applicableWake Forest University Health SciencesNCT01631656Written as Azelaic acid
- Azelaic Acid on Demodex Counts in RosaceaCompletedPhase 2/3Wake Forest UniversityNCT03035955Written as Azelaic acid
See all 25 studies that test azelaic acid →
As the comparator · 2 — what is tested is compared with azelaic acid
- Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular RosaceaCompletedPhase 1LEO PharmaNCT01257919Written as Azelaic Acid Gel
- A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With RosaceaCompletedPhase 3Actavis Inc.NCT03287791Written as Finacea® (Azelaic Acid) Foam
Codes
What other systems call azelaic acid · ClinicalTrials.gg INT002474
- MeSH (NLM) C010038azelaic acidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) F2VW3D43YTAZELAIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 18602Confirmed FDA, Wikidata
- Wikidata Q413504azelaic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47407Azelaic AcidOne source FDA
- DrugBank DB00548One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C010038 | azelaic acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | F2VW3D43YT | AZELAIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 18602 | — | Confirmed FDA, Wikidata |
| Wikidata | Q413504 | azelaic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47407 | Azelaic Acid | One source FDA |
| DrugBank | DB00548 | — | One source Wikidata |
Also registered as dipotassium azelate (UNII C98170693J), disodium azelate (UNII 0P4H8NH3UJ · RxNorm 2117384) and monosodium azelate (UNII 5816841A8F).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.